Homeopathic Divide: FDA Talks Pre-Market Approval As Industry Floats Label Changes

FDA officials point out label changes would not resolve their concerns that homeopathics, unlike other Rx and OTC drug categories, are available without pre-market approval. Stakeholders emphasize the products’ safety while suggesting changes such as more information on labels to better identify ingredients.